HPTN 083‐02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study
Christina Psaros(Harvard University), Adeola Adeyeye(National Institutes of Health), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Steven A. Safren(University of Miami), Keren Middelkoop(Desmond Tutu HIV Foundation), Raphael J. Landovitz(APLA Health), Marybeth McCauley(Family Health International 360), James F. Rooney(Gilead Sciences (United States)), Vivian F. Go(University of North Carolina at Chapel Hill), Sam Griffith(Family Health International 360), Nittaya Phanuphak(HIV Netherlands Australia Thailand Research Collaboration), Jeremy Sugarman(Johns Hopkins Berman Institute of Bioethics), Temitope Oyedele(AstraZeneca (South Korea)), Sheldon D. Fields(Pennsylvania State University), Jesse L. Clark(University of Maryland, Baltimore), Lara E. Coelho(UCLA Medical Center), Jasper S. Lee(Massachusetts General Hospital), Colleen F. Kelley(Emory University), Alex R. Rinehart, Yashna Singh(Desmond Tutu HIV Foundation), Georgia R. Goodman(Brigham and Women's Hospital), Whitney S. Rice(Emory University)
Cited by 9
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k